nach oben

Erschienen in:

16.09.2022 | Koronare Herzerkrankung | CME

Management des chronischen Koronarsyndroms

verfasst von: Udo Sechtem, Andreas Seitz, Peter Ong, Raffi Bekeredjian

Erschienen in: Herz | Ausgabe 5/2022

zum CME-Kurs Einloggen, um Zugang zu erhalten

Zusammenfassung

Die koronare Herzkrankheit ist immer noch die häufigste Todesursache in den Industrieländern. Dieser CME-Artikel greift wichtige Punkte aus den aktuellen Leitlinien zum chronischen Koronarsyndrom der European Society of Cardiology (ESC) bzw. zum Brustschmerz der American Heart Association (AHA)/des American College of Cardiology (ACC) auf und kommentiert sie.

Statista (2022) Häufigste Todesursachen in Ländern mit hohem und niedrigem Einkommen im Jahr 2016. https://de.statista.com/statistik/daten/studie/990596/umfrage/todesursachen-in-laendern-mit-hohem-und-niedrigem-einkommen/. Zugegriffen: 9. Juli 2022

Knuuti J, Wijns W, Saraste A et al (2020) 2019 ESC guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 41:407–477. https://doi.org/10.1093/eurheartj/ehz425 CrossRefPubMed

Saraste A, Knuuti J (2020) ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes: recommendations for cardiovascular imaging. Herz 45:409–420. https://doi.org/10.1007/s00059-020-04935-x CrossRefPubMedPubMedCentral

Writing Committee Members, Gulati M, Levy PD et al (2021) 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR guideline for the evaluation and diagnosis of chest pain: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 78:e187–e285. https://doi.org/10.1016/j.jacc.2021.07.053 CrossRef

Joseph A, Ackerman D, Talley JD et al (1993) Manifestations of coronary atherosclerosis in young trauma victims—an autopsy study. J Am Coll Cardiol 22:459–467 CrossRef

Roffi M, Patrono C, Collet JP et al (2016) 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: task force for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 37:267–315. https://doi.org/10.1093/eurheartj/ehv320 CrossRefPubMed

Collet JP, Thiele H, Barbato E et al (2021) 2020 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 42:1289–1367. https://doi.org/10.1093/eurheartj/ehaa575 CrossRefPubMed

Montalescot G, Sechtem U, Achenbach S et al (2013) 2013 ESC guidelines on the management of stable coronary artery disease: the task force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 34:2949–3003. https://doi.org/10.1093/eurheartj/eht296 CrossRefPubMed

Bairey Merz CN, Pepine CJ, Walsh MN et al (2017) Ischemia and no obstructive coronary artery disease (INOCA): developing evidence-based therapies and research agenda for the next decade. Circulation 135:1075–1092. https://doi.org/10.1161/CIRCULATIONAHA.116.024534 CrossRefPubMed

10.

Kunadian V, Chieffo A, Camici PG et al (2020) An EAPCI expert consensus document on ischaemia with non-obstructive coronary arteries in collaboration with European Society of Cardiology Working Group on Coronary Pathophysiology & Microcirculation. Endorsed by Coronary Vasomotor Disorders International Study Group. Eur Heart J 41:3504–3520. https://doi.org/10.1093/eurheartj/ehaa503 CrossRefPubMedPubMedCentral

11.

Ong P, Athanasiadis A, Perne A et al (2014) Coronary vasomotor abnormalities in patients with stable angina after successful stent implantation but without in-stent restenosis. Clin Res Cardiol 103:11–19. https://doi.org/10.1007/s00392-013-0615-9 CrossRefPubMed

12.

Foldyna B, Udelson JE, Karady J et al (2018) Pretest probability for patients with suspected obstructive coronary artery disease: re-evaluating Diamond-Forrester for the contemporary era and clinical implications: insights from the PROMISE trial. Eur Heart J Cardiovasc Imaging. https://doi.org/10.1093/ehjci/jey182 CrossRefPubMedCentral

13.

Visseren FLJ, Mach F, Smulders YM et al (2021) 2021 ESC guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J 42:3227–3337. https://doi.org/10.1093/eurheartj/ehab484 CrossRefPubMed

14.

Winther S, Schmidt SE, Mayrhofer T et al (2020) Incorporating coronary calcification into pre-test assessment of the likelihood of coronary artery disease. J Am Coll Cardiol 76:2421–2432. https://doi.org/10.1016/j.jacc.2020.09.585 CrossRefPubMed

15.

Lee KK, Wereski R, Williams MC et al (2021) Population screening with coronary computed tomography angiography and the prevention of coronary events. Circulation 144:930–933. https://doi.org/10.1161/CIRCULATIONAHA.121.055784 CrossRefPubMed

16.

Greenwood JP, Ripley DP, Berry C et al (2016) Effect of care guided by cardiovascular magnetic resonance, myocardial perfusion scintigraphy, or NICE guidelines on subsequent unnecessary angiography rates: the CE-MARC 2 randomized clinical trial. JAMA 316:1051–1060. https://doi.org/10.1001/jama.2016.12680 CrossRefPubMed

17.

Lauer MS, Pothier CE, Magid DJ et al (2007) An externally validated model for predicting long-term survival after exercise treadmill testing in patients with suspected coronary artery disease and a normal electrocardiogram. Ann Intern Med 147:821–828. https://doi.org/10.7326/0003-4819-147-12-200712180-00001 CrossRefPubMed

18.

Shaw LJ, Berman DS, Picard MH et al (2014) Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging. JACC Cardiovasc Imaging 7:593–604. https://doi.org/10.1016/j.jcmg.2013.10.021 CrossRefPubMedPubMedCentral

19.

Dewey M, Rief M, Martus P et al (2016) Evaluation of computed tomography in patients with atypical angina or chest pain clinically referred for invasive coronary angiography: randomised controlled trial. BMJ 355:i5441. https://doi.org/10.1136/bmj.i5441 CrossRefPubMedPubMedCentral

20.

Chang HJ, Lin FY, Gebow D et al (2019) Selective referral using CCTA versus direct referral for individuals referred to invasive coronary angiography for suspected CAD: a randomized, controlled, open-label trial. JACC Cardiovasc Imaging 12:1303–1312. https://doi.org/10.1016/j.jcmg.2018.09.018 CrossRefPubMed

21.

Group DT, Maurovich-Horvat P, Bosserdt M et al (2022) CT or invasive coronary angiography in stable chest pain. N Engl J Med 386:1591–1602. https://doi.org/10.1056/NEJMoa2200963 CrossRef

22.

Nagel E, Greenwood JP, McCann GP et al (2019) Magnetic resonance perfusion or fractional flow reserve in coronary disease. N Engl J Med 380:2418–2428. https://doi.org/10.1056/NEJMoa1716734 CrossRefPubMed

23.

De Bruyne B, Fearon WF, Pijls NH et al (2014) Fractional flow reserve-guided PCI for stable coronary artery disease. N Engl J Med 371:1208–1217. https://doi.org/10.1056/NEJMoa1408758 CrossRefPubMed

24.

Xaplanteris P, Fournier S, Pijls NHJ et al (2018) Five-year outcomes with PCI guided by fractional flow reserve. N Engl J Med 379:250–259. https://doi.org/10.1056/NEJMoa1803538 CrossRefPubMed

25.

Hachamovitch R (2015) Does ischemia burden in stable coronary artery disease effectively identify revascularization candidates? Ischemia burden in stable coronary artery disease effectively identifies revascularization candidates. Circ Cardiovasc Imaging 8:e352. https://doi.org/10.1161/CIRCIMAGING.113.000352 CrossRefPubMed

26.

Maron DJ, Hochman JS, Reynolds HR et al (2020) Initial invasive or conservative strategy for stable coronary disease. N Engl J Med 382:1395–1407. https://doi.org/10.1056/NEJMoa1915922 CrossRefPubMedPubMedCentral

27.

Mark DB, Spertus JA, Bigelow R et al (2022) Comprehensive quality-of-life outcomes with invasive versus conservative management of chronic coronary disease in ISCHEMIA. Circulation 145:1294–1307. https://doi.org/10.1161/CIRCULATIONAHA.121.057363 CrossRefPubMed

28.

Patel KK (2022) Improving symptoms and quality of life in stable coronary artery disease: an evolving paradigm. Circulation 145:1308–1311. https://doi.org/10.1161/CIRCULATIONAHA.122.059482 CrossRefPubMed

29.

Vermeltfoort IA, Raijmakers PG, Odekerken DA et al (2009) Association between anxiety disorder and the extent of ischemia observed in cardiac syndrome X. J Nucl Cardiol 16:405–410. https://doi.org/10.1007/s12350-008-9032-2 CrossRefPubMed

30.

Jespersen L, Hvelplund A, Abildstrom SZ et al (2012) Stable angina pectoris with no obstructive coronary artery disease is associated with increased risks of major adverse cardiovascular events. Eur Heart J 33:734–744. https://doi.org/10.1093/eurheartj/ehr331 CrossRefPubMed

31.

Patel KH, Doodnauth AV, Dunkley JC et al (2021) Aborted sudden cardiac death from vasospastic-induced ventricular fibrillation with normal coronary angiography: a case report and review of the literature. Am J Med Case Rep 9:78–82. https://doi.org/10.12691/ajmcr-9-1-20 CrossRefPubMed

32.

Ong P, Athanasiadis A, Sechtem U (2016) Intracoronary acetylcholine provocation testing for assessment of coronary vasomotor disorders. J Vis Exp. https://doi.org/10.3791/54295 CrossRefPubMedPubMedCentral

33.

Yilmaz A, Hill S, Schaufele T et al (2010) Exercise-induced spastic coronary artery occlusion at the site of a moderate stenosis: neither Prinzmetal’s angina nor cardiac syndrome X but “Prinzmetal X”. Circulation 122:e570–e574. https://doi.org/10.1161/CIRCULATIONAHA.110.984823 CrossRefPubMed

34.

Taqueti VR, Hachamovitch R, Murthy VL et al (2015) Global coronary flow reserve is associated with adverse cardiovascular events independently of luminal angiographic severity and modifies the effect of early revascularization. Circulation 131:19–27. https://doi.org/10.1161/CIRCULATIONAHA.114.011939 CrossRefPubMed

35.

Knott KD, Seraphim A, Augusto JB et al (2020) The prognostic significance of quantitative myocardial perfusion: an artificial intelligence-based approach using perfusion mapping. Circulation 141:1282–1291. https://doi.org/10.1161/CIRCULATIONAHA.119.044666 CrossRefPubMedPubMedCentral

36.

Feenstra RGT, Seitz A, Boerhout CKM et al (2022) Principles and pitfalls in coronary vasomotor function testing. EuroIntervention 17:1271–1280. https://doi.org/10.4244/EIJ-D-21-00402 CrossRefPubMed

37.

Grundy SM, Stone NJ, Bailey AL et al (2019) 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol 73:e285–e350. https://doi.org/10.1016/j.jacc.2018.11.003 CrossRefPubMed

Titel: Management des chronischen Koronarsyndroms
verfasst von: Udo Sechtem
Andreas Seitz
Peter Ong
Raffi Bekeredjian
Publikationsdatum: 16.09.2022
Verlag: Springer Medizin
Schlagwörter: Koronare Herzerkrankung
KHK in der Hausarztpraxis
Thoraxschmerzen
Diagnostik in der Kardiologie
Erschienen in: Herz / Ausgabe 5/2022
Print ISSN: 0340-9937
Elektronische ISSN: 1615-6692
DOI: https://doi.org/10.1007/s00059-022-05137-3

Neu im Fachgebiet Innere Medizin

27.01.2023 | COPD | Podcast | Nachrichten

Springer Medizin

Management des chronischen Koronarsyndroms

Zusammenfassung

Neu im Fachgebiet Innere Medizin

Hilfe übers Bronchoskop bei COPD – neue Verfahren im Überblick

Nach ICI-Therapie: Wie häufig ist Diabetes?

UFOs sind weitgehend harmlos, versichert Studie

Vorteile für präoperative Chemotherapie bei Kolon-Ca.

Update Innere Medizin

Update Innere Medizin

Springer Medizin

Zusammenfassung

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 5/2022

Rhythmologische und metabolische Kontrolle

First experiences with a new balloon-expandable Myval transcatheter aortic valve: a preliminary study

Lipidsenkung: neue Substanzen und neue Konzepte

Erratum to: Outcomes of patients with ST-segment myocardial infarction admitted during the COVID-19 pandemic

Association of CHA2DS2-VASc score with thrombus burden in patients with acute myocardial infarction undergoing SVG-PCI

Herz und Diabetes

Neu im Fachgebiet Innere Medizin

Hilfe übers Bronchoskop bei COPD – neue Verfahren im Überblick

Nach ICI-Therapie: Wie häufig ist Diabetes?

UFOs sind weitgehend harmlos, versichert Studie

Vorteile für präoperative Chemotherapie bei Kolon-Ca.

Update Innere Medizin

Update Innere Medizin